SYLUS PHARMACEUTICALS LTD

Active Abingdon

Other human health activities

0 employees website.com
Other human health activities
S

SYLUS PHARMACEUTICALS LTD

Other human health activities

Founded 7 Mar 2002 Active Abingdon, England 0 employees website.com
Other human health activities
Accounts Submitted 18 Dec 2025 Next due 31 Dec 2026 7 months remaining
Confirmation Submitted 9 Mar 2026 Next due 20 Mar 2027 9 months remaining
Net assets £-21K £6K 2024 year on year
Total assets £56K £828 2024 year on year
Total Liabilities £77K £6K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

2a Dunmore Court Wootton Road Abingdon OX13 6BH England

Full company profile for SYLUS PHARMACEUTICALS LTD (04389197), an active company based in Abingdon, England. Incorporated 7 Mar 2002. Other human health activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type micro-entity
Next accounts 31 Mar 2026
Due by 31 Dec 2026 7 months remaining

Balance Sheet & P&L (2014–2024)

Cash in Bank

N/A

Net Assets

-£21.45k

Decreased by £6.43k (-43%)

Total Liabilities

£77.22k

Increased by £5.60k (+8%)

Turnover

N/A

Employees

N/A

Debt Ratio

138%

Increased by 11 (+9%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 8,737 Shares £77k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
2 Nov 20178,737£77k£8.8

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (9)

Bloomsbury Bioseed Fund Limited
33.0%
Promida Holdings Limited
22.5%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Professor Thomas William Rademacher

American

Active
Notified 6 Apr 2016
Residence England
DOB May 1950
Nature of Control
  • Significant Influence Or Control

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
9 Mar 2026Confirmation StatementConfirmation statement made on 6 Mar 2026 with no updates
18 Dec 2025AccountsAnnual accounts made up to 31 Mar 2025
29 Jul 2025GazetteGazette Filings Brought Up To Date
28 Jul 2025Confirmation StatementConfirmation statement made on 6 Mar 2025 with no updates
27 May 2025GazetteGazette Notice Compulsory
9 Mar 2026 Confirmation Statement

Confirmation statement made on 6 Mar 2026 with no updates

18 Dec 2025 Accounts

Annual accounts made up to 31 Mar 2025

29 Jul 2025 Gazette

Gazette Filings Brought Up To Date

28 Jul 2025 Confirmation Statement

Confirmation statement made on 6 Mar 2025 with no updates

27 May 2025 Gazette

Gazette Notice Compulsory

Recent Activity

Latest Activity

Confirmation statement made on 6 Mar 2026 with no updates

2 months ago on 9 Mar 2026

Annual accounts made up to 31 Mar 2025

5 months ago on 18 Dec 2025

Gazette Filings Brought Up To Date

10 months ago on 29 Jul 2025

Confirmation statement made on 6 Mar 2025 with no updates

10 months ago on 28 Jul 2025

Gazette Notice Compulsory

1 years ago on 27 May 2025